Madrigal Pharmaceuticals, Inc. (YDO1.F)
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
399.70-0.06%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+54.1%
The outlook
Madrigal Pharmaceuticals, Inc. currently reads as leaning bearish based on below its 50- & 200-day averages, 54% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range54% of the way from its 52-week low to high
Market cap
$9.22B
52-wk high
523.20
52-wk low
256.10
50-day avg
448.90
200-day avg
438.74
Trailing P/E
—